Study of proteomics for identification of novel prognostic biomarkers in patients with hepatocellular carcinoma and intrahepatic cholangiocarcinoma undergoing surgical resectio
Completed
- Conditions
- Hepatocellular carcinoma and Intrahepatic cholangiocarcinomaHepatocellular carcinoma, Intrahepatic cholangiocarcinoma, Biomarkers, Proteomics, Prognosis
- Registration Number
- TCTR20220113002
- Lead Sponsor
- Ratchadapisek Research Funds
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 115
Inclusion Criteria
patients with hepatocellular carcinoma and intrahepatic cholangiocarcinoma undergoing surgical resection from King Chulalongkorn Memorial Hospital
Exclusion Criteria
1. Smoking
2. Congenital disease
3. A patient who had a bowel resection
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method diagnostic biomarker first visit western blot
- Secondary Outcome Measures
Name Time Method prognostic marker first visit ELISA